Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Holy Grail: the journey towards disease modification in asthma
William W. Busse, Erik Melén, Andrew Menzies‐Gow
European Respiratory Review (2022) Vol. 31, Iss. 163, pp. 210183-210183
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Asthma
Celeste Porsbjerg, Erik Melén, Lauri Lehtimäki, et al.
The Lancet (2023) Vol. 401, Iss. 10379, pp. 858-873
Closed Access | Times Cited: 255
EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023
W.J. Fokkens, A-S Viskens, V. Backer, et al.
Rhinology Journal (2023)
Open Access | Times Cited: 156
Precision medicine in complex diseases—Molecular subgrouping for improved prediction and treatment stratification
Åsa Johansson, Ole A. Andreassen, Søren Brunak, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 4, pp. 378-396
Open Access | Times Cited: 34
New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis
Ilja Střı́ž, Korneliusz Golebski, Zuzana Střížová, et al.
Clinical Science (2023) Vol. 137, Iss. 9, pp. 727-753
Open Access | Times Cited: 33
Targeting Asthma Remission as the Next Therapeutic Step Toward Improving Disease Control
William W. Busse, Geoffrey Chupp, Thomas Corbridge, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 4, pp. 894-903
Open Access | Times Cited: 10
Evaluation of Clinical Remission in Best-Performing Severe Asthmatic Patients Treated for Three Years with Mepolizumab
Diego Bagnasco, Benedetta Bondi, Marco Caminati, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 960-960
Open Access | Times Cited: 7
Disease modification in chronic spontaneous urticaria
Marcus Maurer, Pavel Kolkhir, Manuel P. Pereira, et al.
Allergy (2024) Vol. 79, Iss. 9, pp. 2396-2413
Open Access | Times Cited: 7
Unraveling Asthma Through Single-Cell RNA Sequencing in Understanding Disease Mechanisms
Xingxing Yuan, Chaofan Li, Liuxin Yang, et al.
Journal of Asthma (2025), pp. 1-15
Closed Access
Advancing precision medicine in asthma: Evolution of treatment outcomes
Giorgio Walter Canonica, Gilda Varricchi, Giovanni Paoletti, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 4, pp. 835-840
Closed Access | Times Cited: 12
Changes in Small Airway Physiology Measured by Impulse Oscillometry in Subjects with Allergic Asthma Following Methacholine and Inhaled Allergen Challenge
Henning Stenberg, Rory Chan, Khalid Abd‐Elaziz, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 906-906
Open Access
Procyanidin B2 Mitigate Asthmatic Airway Remodeling by Inhibiting TGF-β1-Induced Airway Smooth Muscle Proliferation through ROS Signaling
Wenyan Liang, Mingzhen Zhang, Hongyu Wang, et al.
Tissue and Cell (2025) Vol. 95, pp. 102863-102863
Closed Access
Diagnostik und medikamentöse Therapie der chronischen Rhinosinusitis
Sven Becker
HNO (2025)
Open Access
Understanding the Clinical Implications of Individual Patient Characteristics and Treatment Choice on the Risk of Exacerbation in Asthma Patients with Moderate–Severe Symptoms
Dave Singh, Sean Oosterholt, Ian Pavord, et al.
Advances in Therapy (2023) Vol. 40, Iss. 10, pp. 4606-4625
Open Access | Times Cited: 10
Severity of adult-onset asthma - a matter of blood neutrophils and severe obesity
Sofia Winsa-Lindmark, Caroline Stridsman, Axel Sahlin, et al.
Respiratory Medicine (2023) Vol. 219, pp. 107418-107418
Open Access | Times Cited: 9
SANI clinical remission definition: a useful tool in severe asthma management
Giorgio Walter Canonica, Diego Bagnasco, Benedetta Bondi, et al.
Journal of Asthma (2024) Vol. 61, Iss. 12, pp. 1593-1600
Open Access | Times Cited: 3
The journey toward disease modification in cow milk protein allergy
Rita Nocerino, Laura R. Carucci, Serena Coppola, et al.
Immunological Reviews (2024) Vol. 326, Iss. 1, pp. 191-202
Open Access | Times Cited: 3
Itaconate as a key regulator of respiratory disease
Christina Michalaki, Gesa J. Albers, Adam J. Byrne
Clinical & Experimental Immunology (2023) Vol. 215, Iss. 2, pp. 120-125
Open Access | Times Cited: 8
Remission: Does it already exist in chronic rhinosinusitis with nasal polyposis?
Yvonne Chan, Andrew Thamboo, Joseph K. Han, et al.
Journal of Otolaryngology - Head and Neck Surgery (2023) Vol. 52, Iss. 1
Open Access | Times Cited: 7
Multidisciplinary Decision-Making—ITAlian Consensus After Two Years of Real Practice on the Management of Severe Uncontrolled CRSwNP by Biologics (ITACA Study)
Eugenio De Corso, Carlotta Pipolo, Marco Caminati, et al.
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 3, pp. 143-154
Closed Access | Times Cited: 2
Consequences of severe asthma exacerbations
William W. Busse
Current Opinion in Allergy and Clinical Immunology (2022)
Closed Access | Times Cited: 8
What is disease modification and is this concept even helpful?
Maximilian Boesch, Florent Baty, Frank Rassouli, et al.
European Journal of Internal Medicine (2024) Vol. 124, pp. 1-4
Closed Access | Times Cited: 1
Beyond T2-asthma biomarkers: risk stratification for NSAID-Exacerbated Respiratory Disease
Jacqueline Pérez‐Pazos, Asunción García‐Sánchez, Miguel Estravís, et al.
ERJ Open Research (2024) Vol. 10, Iss. 4, pp. 00909-2023
Open Access | Times Cited: 1
Xin-Yi-Qing-Fei-Tang and its critical components reduce asthma symptoms by suppressing GM-CSF and COX-2 expression in RBL-2H3 cells
Shulhn-Der Wang, Po‐Ting Chen, Miao-Hsi Hsieh, et al.
Journal of Ethnopharmacology (2024) Vol. 330, pp. 118105-118105
Closed Access | Times Cited: 1
Asthma Remission one, none and one-hundred thousand: the relevance of the patient’s view
Matteo Bonini, Simona Barbaglia, Gianna Camiciottoli, et al.
Journal of Asthma (2024), pp. 1-10
Open Access | Times Cited: 1
New Therapeutics for Heart Failure Worsening: Focus on Vericiguat
Patrizia Russo, Laura Vitiello, Francesca Milani, et al.
(2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top